Skip to main content

Table 1 Demographic information

From: Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial

 

Total

Oxytocin

Placebo

Gender

   

 Male

16 (84%)

9

7

 Female

3 (16%)

1

2

Race

   

 Caucasian

14 (73.7%)

7

7

 Black

1 (5.2%)

1

0

 Hispanic

1 (5.2%)

1

0

 Asian

2 (10.5%)

1

1

 Other

1 (5.2%)

0

1

Group assignment

 

10 (52%)

9 (48%)

Age (standard deviation)

33.2 (13.3)

33.8 (12.7)

32.9 (14.4)

IQ (standard deviation)

107 (24)

99 (22)

118 (19)

  1. Data presented as n (%) unless indicated otherwise.